Production (Stage)
Molecular Partners AG
MOLN
$3.87
-$0.1314-3.29%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | 787.30K | 1.72M | 3.13M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | 787.30K | 1.72M | 3.13M |
| Cost of Revenue | 13.26M | 10.76M | 12.56M | 14.47M | 16.13M |
| Gross Profit | -13.26M | -10.76M | -11.77M | -12.76M | -13.00M |
| SG&A Expenses | 4.70M | 6.09M | 5.09M | 4.91M | 5.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.96M | 16.85M | 17.65M | 19.38M | 21.27M |
| Operating Income | -17.96M | -16.85M | -16.87M | -17.67M | -18.14M |
| Income Before Tax | -18.66M | -12.79M | -18.97M | -16.68M | -12.95M |
| Income Tax Expenses | -2.20K | 2.30K | -- | -- | -- |
| Earnings from Continuing Operations | -18.66M | -12.79M | -18.97M | -16.68M | -12.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.66M | -12.79M | -18.97M | -16.68M | -12.95M |
| EBIT | -17.96M | -16.85M | -16.87M | -17.67M | -18.14M |
| EBITDA | -17.34M | -16.57M | -16.18M | -17.00M | -17.45M |
| EPS Basic | -0.51 | -0.35 | -0.57 | -0.50 | -0.39 |
| Normalized Basic EPS | -0.32 | -0.22 | -0.36 | -0.31 | -0.25 |
| EPS Diluted | -0.51 | -0.35 | -0.57 | -0.50 | -0.39 |
| Normalized Diluted EPS | -0.32 | -0.22 | -0.36 | -0.31 | -0.25 |
| Average Basic Shares Outstanding | 36.87M | 36.88M | 33.19M | 33.18M | 32.87M |
| Average Diluted Shares Outstanding | 36.87M | 36.88M | 33.19M | 33.18M | 32.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |